Member Info for Shukan

if only Hemo would reveal the Nasdaq Global Pharma Collaboration on the Antibodies

WELCOME ABOARD

to be fair the Silver Falcon directors were looking for potential multibagger for RTO

"I suggest the COVID test and treatment need funding and global pharma. I had a 3 >4yr £3b valuation prior to COVID"
Watch this space

J&J

AND WHAT ABOUT THE cdx-ANTIBODIES -not priced in

379M IN ISSUE

he total number of ordinary shares on issue following the issue and Admission of the above Shares will be 1,871,772,225

LOL COMPANY IS DOOMED

indeed - in a rush this morning having to build a Cisco networking structure for a client - catch up later

Announcements incoming on all fronts

Hemogenyx are not developing Corvid-19 antibodies testing kits ! See Below what sets this Company up against the Corvid-19 backdrop.
"Hemogenyx will seek to discover human neutralizing antibodies - antibodies that are typically developed by the human immune system to neutralize invading viral pathogens - that could be used to fight SARS-CoV-2 (the virus that causes COVID-19) infections."
They are ahead of the game because of the ApbHC humanised mice used for modelling in their field of Antibody excellence
its a game changer.

Fact of the matter is the rest of Hemogenyx Portfolio bigger than Covid- , the market just turned the light on . We are ahead of the game in this field so expecting decent results on all fronts

When what is all over ?

https://ir.orgenesis.com/press-releases/detail/102/orgenesis-announces-collaboration-with-hemogenyx-to-develop

here are missing the bigger picture with the Hemo antibodies - the Covid-19 developments will be minor in comparison

I’ve seen £1.20 a month ago ??

https://twitter.com/vmsandler/status/1253676723566260225?s=21

Call booked he didn’t pick up - he does this from time to time he will ring back usually in meetings- I will post back with what he says about the posts on here , I copied and pasted the remarks to as a matter of course - along with the libellous remarks from the other portal about the CEO and Company two people in particular - past couple of years Catch up later thanks

three days ago

The "others" are more important than J&J this will become obvious as we progress on all of the Hemogenyx portfolio, hit 6.9p from one tweet out of the lab back then, the current MC is laughable considering the Nasdaq collaborations and working CDX-antibodies that kill AML/ALL leukaemia cancer cells , the Hemo mice live twice as long as other third party humanised developed mice and with a unique mimicked blood system , let see what they can do for Covid-19 antibodies